Variant report

Variant	esv3446624
Chromosome Location	chr19:36282645-36318788
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:654)
CpG islands
(count:367)
Chromatin interactive
region (count:24)
LncRNA
region (count:10)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:654 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:36310841-36311235	K562	blood:	n/a	n/a
2	ARID3A	chr19:36303629-36304134	HepG2	liver:	n/a	n/a
3	ARID3A	chr19:36313513-36313731	K562	blood:	n/a	n/a
4	ARID3A	chr19:36294457-36294854	K562	blood:	n/a	n/a
5	ARID3A	chr19:36310846-36311224	HepG2	liver:	n/a	n/a
6	ATF1	chr19:36294419-36294961	K562	blood:	n/a	n/a
7	ATF1	chr19:36313596-36313797	K562	blood:	n/a	n/a
8	ATF3	chr19:36288621-36288807	K562	blood:	n/a	n/a
9	BACH1	chr19:36288281-36288350	H1-hESC	embryonic stem cell:	n/a	n/a
10	BATF	chr19:36282622-36282875	GM12878	blood:	n/a	n/a
11	BHLHE40	chr19:36294316-36295062	K562	blood:	n/a	n/a
12	BHLHE40	chr19:36287509-36287696	A549	lung:	n/a	n/a
13	BHLHE40	chr19:36310909-36311126	K562	blood:	n/a	n/a
14	BHLHE40	chr19:36297587-36297787	K562	blood:	n/a	n/a
15	CBX3	chr19:36288575-36288913	K562	blood:	n/a	n/a
16	CBX3	chr19:36292658-36293135	K562	blood:	n/a	n/a
17	CBX3	chr19:36294291-36295052	K562	blood:	n/a	n/a
18	CBX3	chr19:36292716-36293031	K562	blood:	n/a	n/a
19	CCNT2	chr19:36288689-36288732	K562	blood:	n/a	n/a
20	CCNT2	chr19:36294357-36294942	K562	blood:	n/a	n/a
21	CEBPB	chr19:36294458-36294981	K562	blood:	n/a	n/a
22	CEBPB	chr19:36307669-36307979	K562	blood:	n/a	chr19:36307797-36307808 chr19:36307794-36307811 chr19:36307797-36307810
23	CEBPB	chr19:36303693-36304119	HepG2	liver:	n/a	n/a
24	CEBPB	chr19:36295910-36296176	K562	blood:	n/a	n/a
25	CEBPB	chr19:36294609-36294894	K562	blood:	n/a	n/a
26	CEBPB	chr19:36306188-36306345	K562	blood:	n/a	n/a
27	CEBPB	chr19:36303820-36304047	HepG2	liver:	n/a	n/a
28	CEBPB	chr19:36307675-36307940	A549	lung:	n/a	chr19:36307797-36307808 chr19:36307794-36307811 chr19:36307797-36307810
29	CEBPB	chr19:36295956-36296114	IMR90	lung:	n/a	n/a
30	CEBPB	chr19:36310940-36311165	H1-hESC	embryonic stem cell:	n/a	n/a
31	CEBPB	chr19:36303727-36304125	HepG2	liver:	n/a	n/a
32	CEBPB	chr19:36307649-36307913	IMR90	lung:	n/a	chr19:36307797-36307808 chr19:36307794-36307811 chr19:36307797-36307810
33	CEBPB	chr19:36307645-36307931	H1-hESC	embryonic stem cell:	n/a	chr19:36307797-36307808 chr19:36307794-36307811 chr19:36307797-36307810
34	CEBPB	chr19:36295943-36296178	A549	lung:	n/a	n/a
35	CEBPB	chr19:36294424-36294916	K562	blood:	n/a	n/a
36	CEBPB	chr19:36303757-36304097	HepG2	liver:	n/a	n/a
37	CEBPB	chr19:36307647-36307966	HepG2	liver:	n/a	chr19:36307797-36307808 chr19:36307794-36307811 chr19:36307797-36307810
38	CEBPD	chr19:36303647-36304030	HepG2	liver:	n/a	n/a
39	CEBPD	chr19:36294370-36295022	K562	blood:	n/a	n/a
40	CEBPD	chr19:36294373-36295009	K562	blood:	n/a	n/a
41	CEBPD	chr19:36303522-36304142	HepG2	liver:	n/a	n/a
42	CEBPD	chr19:36288637-36289008	HepG2	liver:	n/a	n/a
43	CHD2	chr19:36310929-36311102	HepG2	liver:	n/a	n/a
44	CHD2	chr19:36288595-36288855	H1-hESC	embryonic stem cell:	n/a	n/a
45	CREB1	chr19:36288474-36289173	HepG2	liver:	n/a	n/a
46	CTCF	chr19:36303161-36303212	GM12878	blood:	n/a	chr19:36303183-36303191 chr19:36303180-36303198
47	CTCF	chr19:36311020-36311170	Hela-S3	cervix:	n/a	n/a
48	CTCF	chr19:36311000-36311150	AoAF	blood vessel:	n/a	n/a
49	CTCF	chr19:36310900-36311050	GM12869	blood:	n/a	n/a
50	CTCF	chr19:36311040-36311190	GM12872	blood:	n/a	n/a

(count:367 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:36288702-36288752	HNPCEpiC	eye:	n/a
2	chr19:36288702-36288752	HNPCEpiC	eye:	n/a
3	chr19:36305584-36305634	MCF10A-Er-Src	breast:	n/a
4	chr19:36305049-36305099	AG04449	skin:	fetal
5	chr19:36297670-36297720	SK-N-MC	brain:	n/a
6	chr19:36305049-36305099	GM06990	blood:	n/a
7	chr19:36304079-36304129	BJ	skin:	n/a
8	chr19:36304079-36304129	NHDF-neo	bronchial:	n/a
9	chr19:36303880-36303930	SK-N-MC	brain:	n/a
10	chr19:36297670-36297720	NHBE	bronchial:	n/a
11	chr19:36305584-36305634	GM12878	blood:	n/a
12	chr19:36288702-36288752	Hepatocyte	liver:	n/a
13	chr19:36305584-36305634	NT2-D1	testis:	n/a
14	chr19:36305049-36305099	AG09319	gingival:	n/a
15	chr19:36297670-36297720	U87	brain:	n/a
16	chr19:36304079-36304129	HCPEpiC	choroid plexus:	n/a
17	chr19:36303880-36303930	PFSK-1	brain:	n/a
18	chr19:36305584-36305634	T-47D	breast:	n/a
19	chr19:36288702-36288752	HRPEpiC	eye:	n/a
20	chr19:36304079-36304129	GM12878	blood:	n/a
21	chr19:36297670-36297720	GM19239	blood:	n/a
22	chr19:36303880-36303930	HCT-116	colon:	n/a
23	chr19:36303880-36303930	K562	blood:	n/a
24	chr19:36305049-36305099	K562	blood:	n/a
25	chr19:36304079-36304129	A549	lung:	n/a
26	chr19:36304079-36304129	HEEpiC	esophagus:	n/a
27	chr19:36288702-36288752	HCPEpiC	choroid plexus:	n/a
28	chr19:36305049-36305099	Caco-2	colon:	n/a
29	chr19:36303880-36303930	T-47D	breast:	n/a
30	chr19:36297670-36297720	ProgFib	skin:	n/a
31	chr19:36305584-36305634	ECC-1	luminal epithelium:	n/a
32	chr19:36304079-36304129	NB4	blood:	n/a
33	chr19:36305049-36305099	T-47D	breast:	n/a
34	chr19:36288702-36288752	HEK293	kidney:	embryo
35	chr19:36304079-36304129	H1-hESC	embryonic stem cell:	embryo
36	chr19:36288702-36288752	NH-A	brain:	n/a
37	chr19:36305584-36305634	AG09319	gingival:	n/a
38	chr19:36297670-36297720	HNPCEpiC	eye:	n/a
39	chr19:36297670-36297720	AG04450	lung:	fetal
40	chr19:36304079-36304129	PFSK-1	brain:	n/a
41	chr19:36297670-36297720	HepG2	liver:	n/a
42	chr19:36297670-36297720	GM12891	blood:	n/a
43	chr19:36305049-36305099	AoSMC	blood vessel:	n/a
44	chr19:36303880-36303930	NHDF-neo	bronchial:	n/a
45	chr19:36305049-36305099	ovcar-3	ovarian:	n/a
46	chr19:36305584-36305634	MCF-7	breast:	n/a
47	chr19:36297670-36297720	A549	lung:	n/a
48	chr19:36288702-36288752	AG10803	skin:	n/a
49	chr19:36305049-36305099	NT2-D1	testis:	n/a
50	chr19:36288702-36288752	T-47D	breast:	n/a

(count:24 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:36266545..36269722-chr19:36286322..36289805,3	K562	blood:
2	chr19:36184431..36185252-chr19:36310666..36311379,3	MCF-7	breast:
3	chr19:36184372..36185301-chr19:36310613..36311702,6	K562	blood:
4	chr19:36299820..36302228-chr19:36307263..36309973,2	K562	blood:
5	chr19:36288840..36290820-chr19:36294130..36297003,2	K562	blood:
6	chr19:36281922..36284549-chr19:36300650..36302438,2	K562	blood:
7	chr19:36207093..36207844-chr19:36310862..36311467,2	MCF-7	breast:
8	chr19:36301268..36304054-chr19:36346309..36349120,2	K562	blood:
9	chr19:36207031..36209007-chr19:36310284..36312197,2	MCF-7	breast:
10	chr19:36273138..36275777-chr19:36283531..36286401,2	K562	blood:
11	chr19:36039616..36040774-chr19:36310651..36311548,4	K562	blood:
12	chr19:36310142..36312511-chr19:36338610..36340461,2	K562	blood:
13	chr19:36318467..36319997-chr19:36323805..36326161,2	K562	blood:
14	chr19:36277506..36280414-chr19:36281962..36284399,2	MCF-7	breast:
15	chr19:36257583..36262889-chr19:36280442..36283468,4	MCF-7	breast:
16	chr19:36288840..36290820-chr19:36294130..36297003,2	K562	blood:
17	chr19:36281922..36284549-chr19:36300650..36302438,2	K562	blood:
18	chr19:36207753..36208395-chr19:36310728..36311348,2	MCF-7	breast:
19	chr19:36278394..36281152-chr19:36283077..36286446,4	K562	blood:
20	chr19:36272002..36276478-chr19:36278525..36283309,6	K562	blood:
21	chr19:36207922..36208687-chr19:36310659..36311315,2	MCF-7	breast:
22	chr19:36299820..36302228-chr19:36307263..36309973,2	K562	blood:
23	chr19:36278394..36281474-chr19:36283077..36286266,3	K562	blood:
24	chr19:36184588..36185432-chr19:36310650..36311616,2	MCF-7	breast:

(count:10 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PRODH2-1	chr19:36282005-36282754	ENSG00000225872.2
2	lnc-PRODH2-1	chr19:36283190-36283344	NR_104176
3	lnc-NPHS1-1	chr19:36309325-36311606	ucscGeneNc_uc002nsx_1
4	lnc-PRODH2-1	chr19:36283190-36283344	ENSG00000225872
5	lnc-PRODH2-1	chr19:36288702-36288811	NR_104176
6	lnc-PRODH2-1	chr19:36281919-36282754	NR_104176
7	lnc-PRODH2-1	chr19:36281919-36282754	ENSG00000225872
8	lnc-PRODH2-1	chr19:36288702-36288740	ENSG00000225872.2
9	lnc-PRODH2-1	chr19:36288702-36288787	ENSG00000225872
10	lnc-PRODH2-1	chr19:36283290-36283344	ENSG00000225872.2

No data

Variant related genes	Relation type
PRODH2	TF binding region
ENSG00000225872	TF binding region
PRODH2	CpG island
ENSG00000225872	CpG island
ENSG00000267049	chromatin interactions
ENSG00000272333	chromatin interactions
ENSG00000161270	chromatin interactions
ENSG00000126259	chromatin interactions
ENSG00000167595	chromatin interactions
ENSG00000004777	chromatin interactions
CRLF3	miRNA target sites
NCOA3	miRNA target sites

Extended variants
information (count: 1647 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:1647 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs569176063	chr19:36282699-36282700	Enhancers Weak transcription Bivalent/Poised TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
2	rs575607535	chr19:36282712-36282713	Enhancers Weak transcription Bivalent/Poised TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
3	rs539427188	chr19:36282751-36282752	Enhancers Weak transcription Bivalent/Poised TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
4	rs558151683	chr19:36282770-36282771	Enhancers Weak transcription Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs545847126	chr19:36282794-36282795	Enhancers Weak transcription Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs534294079	chr19:36282799-36282800	Enhancers Weak transcription Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs555949151	chr19:36282815-36282816	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs115757136	chr19:36282819-36282820	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs35285880	chr19:36282820-36282821	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs544859016	chr19:36282839-36282840	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs12610798	chr19:36282840-36282841	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs371763128	chr19:36282909-36282910	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs35906176	chr19:36282928-36282929	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs11668331	chr19:36282937-36282938	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs545453753	chr19:36282955-36282956	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs113213212	chr19:36283035-36283036	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs189913365	chr19:36283047-36283048	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs542035004	chr19:36283067-36283068	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs564125890	chr19:36283117-36283118	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs146562463	chr19:36283126-36283127	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs546296083	chr19:36283129-36283130	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs561494553	chr19:36283141-36283142	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs529046607	chr19:36283147-36283148	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs552714782	chr19:36283162-36283163	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs572753705	chr19:36283191-36283192	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
26	rs533269528	chr19:36283233-36283234	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
27	rs181998600	chr19:36283257-36283258	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
28	rs566861889	chr19:36283265-36283266	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
29	rs560794395	chr19:36283275-36283276	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
30	rs34885866	chr19:36283289-36283290	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs555887594	chr19:36283290-36283291	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
32	rs141321196	chr19:36283291-36283292	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
33	rs538420270	chr19:36283300-36283301	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
34	rs34754725	chr19:36283303-36283304	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
35	rs556740058	chr19:36283304-36283305	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
36	rs578162138	chr19:36283349-36283350	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs113522477	chr19:36283358-36283359	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs557425142	chr19:36283383-36283384	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs572504977	chr19:36283449-36283450	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs144763584	chr19:36283470-36283471	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs112303829	chr19:36283471-36283472	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs561433152	chr19:36283476-36283477	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs528974461	chr19:36283573-36283574	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs544040763	chr19:36283579-36283580	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs562710346	chr19:36283590-36283591	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs533030036	chr19:36283591-36283592	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs551650299	chr19:36283592-36283593	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs11882473	chr19:36283593-36283594	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs145581618	chr19:36283613-36283614	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs549426879	chr19:36283634-36283635	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	21397856	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Liver carcinoma	19366792	CNVD
Ovarian cancer	20844748	CNVD
Non-small cell lung cancer	21829676	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Cancer	21183584	CNVD
Honadal dysgenesis	21048976	CNVD
Neurodevelopmental disorder	22521361	CNVD
Endometrial cancer	23636398	CNVD
Disorders of sex development	21048976	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Gastric cancer	21811585	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Glioma	17123091	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Lung cancer	21569311	CNVD
Breast cancer	21509527	CNVD

Chromatin state (count:331 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:36267800-36284200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
2	chr19:36268400-36284200	Weak transcription	K562	blood
3	chr19:36273000-36282800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
4	chr19:36273200-36284200	Weak transcription	Osteobl	bone
5	chr19:36273600-36283400	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
6	chr19:36273600-36288000	Weak transcription	Brain Angular Gyrus	brain
7	chr19:36273800-36284000	Weak transcription	Esophagus	oesophagus
8	chr19:36274000-36284000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
9	chr19:36274200-36284000	Weak transcription	Brain Anterior Caudate	brain
10	chr19:36274600-36284000	Weak transcription	Monocytes-CD14+_RO01746	blood
11	chr19:36277200-36284400	Weak transcription	Placenta Amnion	Placenta Amnion
12	chr19:36277400-36288200	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
13	chr19:36277600-36284800	Weak transcription	Gastric	stomach
14	chr19:36277800-36283200	Weak transcription	Fetal Thymus	thymus
15	chr19:36278400-36288000	Weak transcription	Brain Inferior Temporal Lobe	brain
16	chr19:36278400-36294400	Weak transcription	Spleen	Spleen
17	chr19:36278600-36284000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
18	chr19:36278600-36284200	Weak transcription	Primary monocytes fromperipheralblood	blood
19	chr19:36278600-36284200	Weak transcription	NHLF	lung
20	chr19:36278600-36284600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
21	chr19:36279000-36285000	Weak transcription	Cortex derived primary cultured neurospheres	brain
22	chr19:36279200-36284800	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
23	chr19:36279200-36285000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
24	chr19:36279400-36285800	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
25	chr19:36281000-36285600	Weak transcription	Primary neutrophils fromperipheralblood	blood
26	chr19:36281200-36287200	Weak transcription	Fetal Brain Female	brain
27	chr19:36281200-36287600	Weak transcription	Brain Germinal Matrix	brain
28	chr19:36281800-36283400	Enhancers	Pancreas	Pancrea
29	chr19:36282000-36282800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
30	chr19:36282200-36284200	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
31	chr19:36282400-36282800	Enhancers	HepG2	liver
32	chr19:36282400-36283600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
33	chr19:36282400-36284200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr19:36282600-36284800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
35	chr19:36282600-36285200	Enhancers	Stomach Mucosa	stomach
36	chr19:36282800-36283000	Enhancers	Fetal Intestine Small	intestine
37	chr19:36282800-36283600	Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
38	chr19:36282800-36284000	Weak transcription	HepG2	liver
39	chr19:36283400-36283800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
40	chr19:36283400-36303000	Weak transcription	Pancreas	Pancrea
41	chr19:36283600-36283800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
42	chr19:36283800-36284000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
43	chr19:36283800-36284000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
44	chr19:36284000-36284200	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr19:36284000-36284200	Enhancers	Esophagus	oesophagus
46	chr19:36284000-36285000	Enhancers	HepG2	liver
47	chr19:36284000-36285200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
48	chr19:36284000-36285200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
49	chr19:36284000-36285200	Enhancers	NHDF-Ad	bronchial
50	chr19:36284200-36284400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links